UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized phase III study comparing a new 13.5 mg levonorgestrel intrauterine contraceptive system with a combined oral contraceptive: analysis of efficacy and bleeding profiles

Fertility and sterility, 2014-09, Vol.102 (3), p.e143-e143

2014

Volltextzugriff (PDF)

A multicenter, randomized phase III study comparing a 13.5 mg levonorgestrel intrauterine contraceptive system with a combined oral contraceptive: analysis of user satisfaction and safety

Fertility and sterility, 2014-09, Vol.102 (3), p.e12-e12

2014

Volltextzugriff (PDF)

A 12-month multicenter, randomized phase III study comparing a 13.5 mg levonorgestrel intrauterine contraceptive system with the etonogestrel subdermal contraceptive implant in women aged 18–35 years

Fertility and sterility, 2014-09, Vol.102 (3), p.e142-e142

2014

Volltextzugriff (PDF)

A phase III single-arm study of a new 13.5 mg levonorgestrel intrauterine contraceptive system in postmenarcheal adolescents: an evaluation of efficacy, bleeding, user satisfaction, and placement

FERTILITY AND STERILITY, 2014-09, Vol.102 (3), p.e141-e142

2014

Volltextzugriff (PDF)

A multicenter, open-label, single-arm study exploring the safety of a new 13.5 mg total dose levonorgestrel intrauterine contraceptive system in postmenarcheal adolescents

FERTILITY AND STERILITY, 2014-09, Vol.102 (3), p.e12-e13

2014

Volltextzugriff (PDF)

Bleeding profiles of two low-dose levonorgestrel-releasing intrauterine systems (LNG-IUSs) used for contraception in nulliparous and parous women: results of a global, randomized, phasE III study

Fertility and sterility, 2012-09, Vol.98 (3), p.S194-S194

2012

Volltextzugriff (PDF)

A global, randomized, phase III, pearl index study comparing the efficacy and safety of two low-dose levonorgestrel-releasing intrauterine systems (LNG-IUSS) in nulliparous and parous women

Fertility and sterility, 2012-09, Vol.98 (3), p.S5-S5

2012

Volltextzugriff (PDF)

Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial

Obstetrics and gynecology (New York. 1953), 2013-12, Vol.122 (6), p.1205-1213

2013

Volltextzugriff (PDF)

A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant

Fertility and sterility, 2016-07, Vol.106 (1), p.151-157.e5

2016

Volltextzugriff (PDF)

The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial

PloS one, 2015-09, Vol.10 (9), p.e0135309-e0135309

2015

Volltextzugriff (PDF)

135P Characteristics and dosing patterns of US patients diagnosed with HR+/HER2- early breast cancer initiating abemaciclib at a lower dose than the approved 150mg BID

ESMO open, 2024-05, Vol.9, p.103122, Article 103122

2024

Volltextzugriff (PDF)

How to define the gray issue of accountability

Managed healthcare executive, 1997-01, Vol.7 (1), p.20

1997

Volltextzugriff (PDF)

Examining the Role of Patient Experience Surveys in Measuring Health Care Quality

Medical Care Research and Review, 2014-10, Vol.71 (5), p.522-554

2014

Volltextzugriff (PDF)

Taking Patients’ Narratives about Clinicians from Anecdote to Science

The New England journal of medicine, 2015-08, Vol.373 (7), p.675-679

2015

Volltextzugriff (PDF)

Analysis of Key Factors Influencing Spice Traceability Systems: The Example of Black Pepper (Piper nigrum L.)

Zeszyty naukowe (Uniwersytet Ekonomiczny w Krakowie), 2024-01 (3(1001)), p.67-84

2024

Volltextzugriff (PDF)

Analysis of Key Factors Influencing Spice Traceability Systems: The Example of Black Pepper (Piper nigrum L.)

Zeszyty naukowe (Uniwersytet Ekonomiczny w Krakowie), 2023, Vol.1001 (3), p.67-84

2023

Volltextzugriff (PDF)

Physician Information: The Authors Reply

Health Affairs, 2019-06, Vol.38 (6), p.1055-1055

2019

Volltextzugriff (PDF)

Evaluation of a protocol for eliciting narrative accounts of pediatric inpatient experiences of care

Health services research, 2023-04, Vol.58 (2), p.271-281

2023

Volltextzugriff (PDF)

A Rigorous Approach to Large-Scale Elicitation and Analysis of Patient Narratives

Medical care research and review, 2020-10, Vol.77 (5), p.416-427

2020

Volltextzugriff (PDF)

Americans’ Growing Exposure To Clinician Quality Information: Insights And Implications

Health Affairs, 2019-03, Vol.38 (3), p.374-382

2019

Volltextzugriff (PDF)

Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2− metastatic breast cancer

Current medical research and opinion, 2021-07, Vol.37 (7), p.1179-1187

2021

Volltextzugriff (PDF)

Real-world health-related quality of life and caregiver need in patients with metastatic hormone-sensitive and metastatic castration-resistant prostate cancer

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.54-54

2022

Volltextzugriff (PDF)

Real-world outcomes in patients with brain metastases secondary to HR+/HER2- MBC treated with abemaciclib and local intracranial therapy

The oncologist (Dayton, Ohio), 2024-10

2024

Volltextzugriff (PDF)

Choosing Doctors Wisely: Can Assisted Choice Enhance Patients’ Selection of Clinicians?

Medical care research and review, 2019-10, Vol.76 (5), p.572-596

2019

Volltextzugriff (PDF)

Abstract PS10-46: Real-world patient characteristics, utilization patterns, and outcomes of US patients with HR+/HER2- metastatic breast cancer treated with abemaciclib

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS10-46-PS10-46

2021

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A randomized phase III study comparing a new 13.5 mg levonorgestrel intrauterine contraceptive system with a combined oral contraceptive: analysis of efficacy and bleeding profiles

A multicenter, randomized phase III study comparing a 13.5 mg levonorgestrel intrauterine contraceptive system with a combined oral contraceptive: analysis of user satisfaction and safety

A 12-month multicenter, randomized phase III study comparing a 13.5 mg levonorgestrel intrauterine contraceptive system with the etonogestrel subdermal contraceptive implant in women aged 18–35 years

A phase III single-arm study of a new 13.5 mg levonorgestrel intrauterine contraceptive system in postmenarcheal adolescents: an evaluation of efficacy, bleeding, user satisfaction, and placement

A multicenter, open-label, single-arm study exploring the safety of a new 13.5 mg total dose levonorgestrel intrauterine contraceptive system in postmenarcheal adolescents

Bleeding profiles of two low-dose levonorgestrel-releasing intrauterine systems (LNG-IUSs) used for contraception in nulliparous and parous women: results of a global, randomized, phasE III study

A global, randomized, phase III, pearl index study comparing the efficacy and safety of two low-dose levonorgestrel-releasing intrauterine systems (LNG-IUSS) in nulliparous and parous women

Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial

A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant

The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial

135P Characteristics and dosing patterns of US patients diagnosed with HR+/HER2- early breast cancer initiating abemaciclib at a lower dose than the approved 150mg BID

How to define the gray issue of accountability

Examining the Role of Patient Experience Surveys in Measuring Health Care Quality

Taking Patients’ Narratives about Clinicians from Anecdote to Science

Analysis of Key Factors Influencing Spice Traceability Systems: The Example of Black Pepper (Piper nigrum L.)

Analysis of Key Factors Influencing Spice Traceability Systems: The Example of Black Pepper (Piper nigrum L.)

Physician Information: The Authors Reply

Evaluation of a protocol for eliciting narrative accounts of pediatric inpatient experiences of care

A Rigorous Approach to Large-Scale Elicitation and Analysis of Patient Narratives

Americans’ Growing Exposure To Clinician Quality Information: Insights And Implications

Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2− metastatic breast cancer

Real-world health-related quality of life and caregiver need in patients with metastatic hormone-sensitive and metastatic castration-resistant prostate cancer

Real-world outcomes in patients with brain metastases secondary to HR+/HER2- MBC treated with abemaciclib and local intracranial therapy

Choosing Doctors Wisely: Can Assisted Choice Enhance Patients’ Selection of Clinicians?

Abstract PS10-46: Real-world patient characteristics, utilization patterns, and outcomes of US patients with HR+/HER2- metastatic breast cancer treated with abemaciclib

Suchergebnisse filtern